Publications by authors named "Javier Casinello"
Article Synopsis
- The study investigates the long-term outcomes of patients with metastatic renal cell carcinoma who achieved a complete response to the TKI sunitinib, revealing little known prior information about this group.
- Data was collected from a registry of 62 patients treated in Spain between 2007 and 2018, with most patients having clear cell histology and previously undergoing nephrectomy.
- Results show that 75% of patients maintained complete response status after 10 years, indicating durable responses across different prognosis groups and metastasis sites.
Unlabelled: SUMMARY
Aim: This study evaluated health outcomes in patients with cancer pain during treatment with transdermal buprenorphine, including quality of life, effectiveness, tolerability, and functional consequences for patients and their carers.
Methods: In this 3-month, noncomparative, multicenter, observational study performed in a normal clinical practice setting in Spain, patients received transdermal buprenorphine 37, 52.5 or 70 µg/h, with patches changed every 96 h.
A patient with inflammatory breast carcinoma (IBC) diagnosed in the left breast responded to cisplatin and was treated with radical mastectomy and adjuvant therapy. Two years later C-erbB2-positive IBC was diagnosed in the right breast, and was treated with mastectomy and radiotherapy. Two years later skin metastases appeared, and trastuzumab was started initially as monotherapy, and later with paclitaxel and capecitabine.
View Article and Find Full Text PDF